Providing care to marginalised communities: a qualitative study of community pharmacy teams
British Journal of General Practice · 2024
DOI: 10.3399/bjgp.2023.0267 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift British Journal of General Practice, 2024. Verfasst von Helen Gibson und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Health and Care Research (NIHR) School for Primary Care Research, School of Health Sciences, Faculty of Biology, Medicine and …. Hauptthemen laut MEDLINE: Pharmacies, Community Pharmacy Services, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Health inequalities in the UK are widening, particularly since the COVID-19 pandemic. Community pharmacies are the most visited healthcare provider in England and are ideally placed to provide and facilitate access to care for those most disadvantaged.
Aim
To explore the experiences and needs of community pharmacy teams in providing care for marginalised groups and how this has changed since the COVID-19 pandemic. Design and setting A qualitative study in community pharmacy and across primary care.
Method
Semi-structured interviews were undertaken with members of community pharmacy teams, primary care network (PCN) pharmacists, GPs, and nurses in the North of England.
Results
In total, 31 individuals participated in an interview (26 pharmacy staff, three GPs, and two nurses). Most participants acknowledged that their pharmacy had become busier since COVID-19 because of increased footfall compounded by patient difficulties in navigating remote digital systems. Few participants had received any formal training on working with marginalised communities; however, organisational barriers (such as lack of access to translation facilities) combined with interorganisational barriers (such as lack of integrated care) made it more difficult to provide care for some marginalised groups. Despite this, the continuity of care provided by many pharmacies was viewed as an important factor in enabling marginalised groups to access and receive care.
Conclusion
There are opportunities to better utilise the skills of community pharmacy teams. Resources, such as access to translation services, and interventions to enable better communication between community pharmacy teams and other primary care services, such as general practice, are essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Health and Care Research (NIHR) School for Primary Care Research, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; NIHR Greater Manchester Patient…
- NIHR School for Primary Care Research, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; NIHR Greater Manchester Patient Safety Research Collaboration, The University of M…
- Wolfson Institute of Population Health, Queen Mary University of London, London.
ORCID-Profile: Helen Gibson, Caroline Sanders, Thomas Blakeman, Darren M Ashcroft, Nina Fudge, Kelly Howells
Zitieren
APA
Gibson, H., Sanders, C., Blakeman, T., Ashcroft, D. M., Fudge, N., & Howells, K. (2024). Providing care to marginalised communities: a qualitative study of community pharmacy teams. British Journal of General Practice. https://doi.org/10.3399/bjgp.2023.0267
Vancouver
Gibson H, Sanders C, Blakeman T, Ashcroft DM, Fudge N, Howells K. Providing care to marginalised communities: a qualitative study of community pharmacy teams. British Journal of General Practice. 2024. doi:10.3399/bjgp.2023.0267
BibTeX
@article{Gibson2024,
author = {Gibson, Helen and Sanders, Caroline and Blakeman, Thomas and Ashcroft, Darren M and Fudge, Nina and Howells, Kelly},
title = {Providing care to marginalised communities: a qualitative study of community pharmacy teams},
journal = {British Journal of General Practice},
year = {2024},
doi = {10.3399/bjgp.2023.0267}
}
EUVIMED